Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Salit

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Pharmacoeconomics|April 7, 1998
Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patientsG Dranitsaris, P Phillips, C Rotstein, et al.
International Journal of STD & AIDS|December 4, 2008
Is there a reservoir of sub-clinical lymphogranuloma venereum and non-LGV Chlamydia trachomatis infection in men who have sex with men?J Tinmouth, M W Gilmour, C Kovacs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study GroupS D Shafran, J A Talbot, S Chomyc, et al.
The New England Journal of Medicine|August 8, 1996
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study GroupS D Shafran, J Singer, D P Zarowny, et al.
European Journal of Clinical Nutrition|May 25, 2006
A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndromeJ Austin, N Singhal, R Voigt, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Pharmacoeconomics|April 7, 1998
Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patientsG Dranitsaris, P Phillips, C Rotstein, et al.
International Journal of STD & AIDS|December 4, 2008
Is there a reservoir of sub-clinical lymphogranuloma venereum and non-LGV Chlamydia trachomatis infection in men who have sex with men?J Tinmouth, M W Gilmour, C Kovacs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study GroupS D Shafran, J A Talbot, S Chomyc, et al.
The New England Journal of Medicine|August 8, 1996
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study GroupS D Shafran, J Singer, D P Zarowny, et al.
European Journal of Clinical Nutrition|May 25, 2006
A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndromeJ Austin, N Singhal, R Voigt, et al.
Pageof 3